ArticleHaematologica2022

Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14).

Anna Kalff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.